Imuran and Botox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imuran (azathioprine) and Botox (botulinum toxin type a). Common drug interactions include headache among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Imuran and Botox. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Imuran?

Imuran has active ingredients of azathioprine. It is often used in crohn's disease. eHealthMe is studying from 34,915 Imuran users. Check the latest studies of Imuran.

What is Botox?

Botox has active ingredients of botulinum toxin type a. It is often used in migraine. eHealthMe is studying from 70,513 Botox users. Check the latest studies of Botox.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Jul, 04, 2026

35 people who take Imuran and Botox together, and have interactions are studied.

Imuran and Botox drug interactions.

What are the common drug interactions of Imuran and Botox, by gender? *:

female:

  1. Headache (pain in head)
  2. Pain
  3. Sinusitis (inflammation of sinus)
  4. Drug intolerance (drug sensitivity)
  5. Nausea (feeling of having an urge to vomit)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Cellulitis (infection under the skin)
  8. Drug ineffective
  9. Iritis (painful inflammation of the iris of the eye)
  10. Vision blurred

male:

  1. Drug ineffective
  2. Abdominal adhesions (inflammation of abdomen)
  3. Nausea (feeling of having an urge to vomit)
  4. Adverse event
  5. Obstruction
  6. Constipation
  7. Gastrointestinal pain
  8. Hypophagia (reduced food intake)
  9. Intestinal obstruction
  10. Pain

What are the common drug interactions of Imuran and Botox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Headache (pain in head)
  4. Neck pain
  5. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)

40-49:

  1. Dry eye (lack of adequate tears)
  2. Injection site reaction

50-59:

  1. Abdominal adhesions (inflammation of abdomen)
  2. Constipation
  3. Drug ineffective
  4. Gastrointestinal pain
  5. Hypophagia (reduced food intake)
  6. Intestinal obstruction
  7. Pain
  8. Sinusitis (inflammation of sinus)
  9. Vomiting
  10. Weight decreased

60+:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Muscle tightness
  4. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  5. Myalgia (muscle pain)
  6. Neck pain
  7. Pain
  8. Pain in extremity
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 22.86%
  2. High Blood Cholesterol: 4 people, 11.43%
  3. Headache (pain in head): 4 people, 11.43%
  4. High Blood Pressure: 4 people, 11.43%
  5. Diarrhea: 3 people, 8.57%
  6. Head Injury: 3 people, 8.57%
  7. Intervertebral Disc Degeneration (spinal disc degeneration): 3 people, 8.57%
  8. Iridocyclitis (inflammation of the iris and ciliary body of the eye): 3 people, 8.57%
  9. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 8.57%
  10. Pain: 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Imuran and Botox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imuran and Botox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imuran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Botox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imuran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Botox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on azathioprine and botulinum toxin type a (the active ingredients of Imuran and Botox, respectively), and Imuran and Botox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: